Company
Headquarters: Taipei, Taiwan
TW$616.0 Million
TWD as of Jan. 1, 2024
US$20.1 Million
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally. It also develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd. and changed its name to S&S Healthcare Holding Ltd. in August 2020. S&S Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
S&S Healthcare Holding Ltd has the following listings and related stock indices.
Stock: TWSE: 4198 wb_incandescent